Bernstein Oracle · ORCL

Bernstein SocGen Group Lowers Oracle Price Target to $313

Analyst: Mark L. Moerdler 1 min read Reproduced verbatim
Rating
Outperform
Target
$313
from $339 (−8%)
Upside
+172%
ORCL at $115 today
Bernstein and Oracle logos

What the analyst said

Bernstein SocGen Group analyst Mark L.

Moerdler lowered the price target on Oracle (NYSE: ORCL) to $313.00 (from $339.00) while maintaining an Outperform rating.

“What will be the financial impact of the capital raise?

One of the major overhangs on ORCL has been uncertainty surrounding how Oracle would fund the AI datacenter build-out to meet the contracts signed last year.

Last Monday, Oracle announced a $45B – $50B debt and equity program. We estimate it’ll meet funding requirements through FY28 (possibly longer). Here, we model the debt, convertible and equity raises.

With an understanding of the impact on the financials in-place we believe some of the Oracle concerns should start to abate.

We lowered our price target to $313, updating our model with new debt and equity information and lower P/FE multiple from 30x to 28x to reflect peer valuation given the DC buildout-related controversy.

We see this as a solid entry point on what will be one of the few revenue and EPS acceleration stories in software.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $115. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $313 target is 35% above the median.

Since the note ORCL has moved −19% (from $143). 12-month window: day 269 of 365, closes on February 9, 2027.

Track record

This callOpen: ORCL has not reached $313 yet. This 12-month target is scored on February 9, 2027.

Firm track recordBernstein: 79% of its 24 targets at least a year old were reached within 12 months (#14 of 26 firms). Accuracy ranking →

Bernstein on Oracle

Bernstein price targets on Oracle

6 calls from February 9, 2026 to October 27, 2026. The target went from $313 to $325 (+4%). The rating stayed Buy.

Bernstein targetORCL share price
  1. October 27, 2026Kept the $325 targetBuy$325
  2. September 11, 2026Kept the $325 targetBuy$325
  3. June 11, 2026Target raised from $319 (+2%)Buy$325
  4. March 30, 2026Kept the $319 targetBuy$319
  5. March 11, 2026Target raised from $313 (+2%)Buy$319
  6. February 9, 2026 This noteEarliest call shownBuy$313
Share

Other analysts on Oracle

ScotiabankBuy Cut price target −5%, kept rating Oct 29 $205from $215 GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.